Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) Due to Particulate Matter | Business Wire
The Medicines Company settles patent infringement lawsuits with Teva | NASDAQ:MDCO
teva pharmaceuticals ltd News and Updates from The Economic Times - Page 1
Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) Due to Particulate Matter | Business Wire
Patent Docs: Eli Lilly & Co. v. Teva Parenteral Medicines, Inc. (Fed. Cir. 2012)